ReviewTargeted oncology2025

HER2-Positive Urothelial Carcinoma: Current Evidence on Targeted Agents and Immunotherapy-Based Combinations.

Federica Ciciriello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.